Nanomedicine Advances in Tumor Therapy: Theranostic Approaches and 3D culture systems

Edited by:

Kyung Oh Jung, PhD, Seoul National University, South Korea
Ji Yong Park, PhD, Seoul National University, South Korea

Submission Status: Open | Submission Deadline: 5 April 2025

Health Nanotechnology is calling for submissions to our Collection on Nanomedicine Advances in Tumor Therapy: Theranostic Approaches and 3D Culture Systems. This Collection aims to showcase innovative research in the field of nanomedicine applied to tumor therapy, with a specific emphasis on theranostic approaches and 3D culture systems.

Image credit: © freshidea / Stock.adobe.com

Submit to Collection

Meet the Guest Editors

Back to top

Kyung Oh Jung, PhD, Seoul National University, South Korea

Dr. Jung's research interests exclusively focused on cancer imaging, diagnostics, and therapy, either pre-clinically in small animals and cell cultures, or clinically in patients. It has provided with various backgrounds in biological disciplines including molecular biology, biochemistry, and radiation physics. In molecular level, cell genetic modification with various kind of reporter gene vector for fluorescence, bioluminescence, and nuclear medicine imaging such as SPECT and PET. Especially, bioengineering or biomedical engineering cells, and nanoparticles could be used with many kinds of cell lines including cancer cells, immune cells, stem cells, and so on. Furthermore, a variety of images in mouse models could be acquired using optical imaging system, Animal PET/CT, SPECT/CT, and so on.

Ji Yong Park, PhD, Seoul National University, South Korea

Dr. Ji Yong Park is a Research Professor at the Institute of Radiation Medicine, Seoul National University. He holds a Ph.D. and an M.Sc. in Biomedical Sciences from Seoul National University. Over the past five years, Dr. Park has made significant contributions to the fields of radiopharmaceuticals and nanoparticle-based imaging techniques. He has authored 32 journal articles, including eight as the first author, and holds several patents in disease tracking and cancer treatment platforms. Notably, he has pioneered the development and commercialization of albumin-based click chemistry platforms for theranostics. His achievements include the Asian and Oceanian Young Investigator Award from the Japanese Society of Nuclear Medicine in 2023.

About the Collection

Health Nanotechnology is calling for submissions to our Collection on Nanomedicine Advances in Tumor Therapy: Theranostic Approaches and 3D Culture Systems. This Collection aims to showcase innovative research in the field of nanomedicine applied to tumor therapy, with a specific emphasis on theranostic approaches and 3D culture systems. We welcome submissions that explore the intersection of nanotechnology and medicine, with a focus on improving healthcare and disease management.

Advances in nanomedicine have revolutionized tumor therapy by offering targeted and personalized treatment options. Nanoscale materials and interfaces have enabled the development of novel drug delivery systems, molecular imaging techniques, and biosensors, leading to more precise and effective cancer treatments. Furthermore, the integration of 3D culture systems has provided researchers with advanced models for studying tumor behavior and drug responses, bridging the gap between traditional cell cultures and in vivo studies. Continued research in this area is crucial for further enhancing the efficacy and safety of cancer therapies, ultimately improving patient outcomes and quality of life.

List of Topics:
1. Nanocarriers for targeted drug delivery in tumor therapy
2. Theranostic nanomedicine for real-time monitoring and treatment of tumors, including endo- and exogenous applications
3. 3D culture systems for studying tumor behavior and drug responses, including mechanisms and targeting cancer
4. Personalized nanomedicine approaches for customized cancer treatments, including therapeutic approaches and formulations
5. Integration of artificial intelligence and nanotechnology in cancer therapy, including modality-based contrast agents and clinical settings
6. Multifunctional nanosystems for precise tumor targeting and treatment, including advancements in commercialization stage

Image credit: © freshidea / Stock.adobe.com

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of research articles, methodologies and reviews. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal.

Articles for this Collection should be submitted via our submission system, Snapp. Please, select the appropriate Collection title “Nanomedicine Advances in Tumor Therapy: Theranostic Approaches and 3D culture systems" under the “Details” tab during the submission stage.

Articles will undergo the journal’s standard peer-review process and are subject to all the journal’s standard policies. Articles will be added to the Collection as they are published.

The Editors have no competing interests with the submissions which they handle through the peer-review process. The peer-review of any submissions for which the Editors have competing interests is handled by another Editorial Board Member who has no competing interests.